Table 1.

Pattern of plasma L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) concentrations (μM, median (IQR)) over the first 7 days of the VANISH trial

	Inclusion	Day 3	Day 5	Day7
L-arginine	25.3 (17.2–35.1)	30.0 (22.8–42.4)	32.6 (25.2–47.5)	32.9 (24.2–47.3)
ADMA	1.6 (1.17–2.2)	1.8 (1.3–2.4)	2.0 (1.6–2.7)	2.2 (1.6–2.8)
SDMA	3.4 (2.0–5.2)	3.4 (1.8–5.3)	3.4 (2.0–5.2)	3.1 (1.7–4.8)